Rising prevalence of gestational diabetes mellitus and its associated risk factors in Makurdi, North-Central Region of Nigeria Authors: Bruno Basil, Izuchukwu N Mba, Terna A Gav, Blessing K Myke-Mbata, Terrumun Z Swende, Simeon A Adebisi Published: 2023 ABSTRACT AbstractBackgroundThe disease burden of gestational diabetes mellitus (GDM) in sub-Saharan African region have been on the rise. Proper assessment of current prevalence of GDM may inform policy changes and management approach for improved care delivery.ObjectiveTo determine the current prevalence of Gestational Diabetes Mellitus (GDM) and evaluate its major risk factors amongst pregnant women in Makurdi, North-Central Nigeria.MethodThis was a multi-center hospital-based prospective observational study. Maternal characteristics and clinical risk factors for GDM in a cohort of 281 pregnant women at 9 to 16 weeks gestational age was evaluated. The one-step 75g oral glucose tolerance test (OGTT) was carried out at 24 to 28 weeks of gestation.ResultOf the 356 women recruited, 281 (79.8%) completed the study. The GDM prevalence in the cohort was 16.7%. Increased early pregnancy BMI (adjusted OR = 1.154, 95% CI = 1.080 – 1.233, p<0.001) and presence of family history of diabetes mellitus (adjusted OR = 0.482, 95% CI = 0.233 – 0.997, P<0.05) were independent risk factors for GDM in the cohort.ConclusionIncreasing maternal age and early pregnancy BMI amongst other possible reasons, may account for the rising prevalence of GDM in the region.Keywords: Pregnancy diabetes mellitus, prevalence, risk factor Introduction Dysglycaemia in pregnancy which occurs as a result of Gestational Diabetes Mellitus (GDM) is associated with high risk of various complications both for the mother and foetus.1, 2 It alters the foetal milieu predisposing to possible epigenetic changes which may increase the risk of chronic metabolic diseases later in adult life.3 In addition to many other possible complications, this may also predispose the mother to increased risk of developing overt Type 2 diabetes mellitus (T2DM) later on.2 Gestational diabetes mellitus, is one of the commonest medical complications of pregnancy. It occurs when pancreatic beta-cells can no longer compensate for increasing insulin resistance 4 and is defined as any degree of glucose intolerance with onset, or first recognition during pregnancy.5 This definition does not exclude undiagnosed diabetes mellitus detected for the first time in the index pregnancy.6 The global prevalence of GDM is estimated to be 8.3%.7 In African, Hispanic, Indian, and Asian women prevalence are higher compared to Caucasian women.8 GDM prevalence in sub-Saharan Africa (SSA) is variable. Prevalence as low as 3.7% have been reported in some rural African settings9 while a crude prevalence of 13.9% was found amongst women at high risk for GDM in an urban population in Nigeria.10 These variable reports suggests the possibility of an increase in the prevalence of GDM which may have occurred over time.11–15 This may be as a result of increasing maternal age, body mass index (BMI), lifestyle changes corresponding to increasing incidence of type 2 diabetes mellitus (T2DM), changes in diagnostic criteria and/or changing definitions of GDM amongst other likely reasons.16 Common risk factors for GDM and associated complications include increasing maternal age, previous GDM, previous hyperglycaemia, increasing maternal BMI, family history of diabetes in first degree relative, previous large for gestational age pregnancy, polycystic ovarian syndrome (PCOS), previous perinatal loss, multiple pregnancies and use of medications such as antipsychotics and corticosteroids.6, 17 However, the short- and long-term maternal and foetal complications associated with GDM1–3 may be significantly reduced via proper identification and management, especially if instituted early in pregnancy.18 It is suggested that there has been remarkable increase in the prevalence and disease burden of GDM over time in various sub-Saharan African populations, 19–22 but no documented evidence of such changes in the North-Central region of Nigeria exists based on information available to the investigators. A proper assessment of the prevalence of GDM would inform policy decisions aimed towards improved identification and management of GDM,23 as well as reduction of its disease burden in the study area. This study was aimed at assessing and documenting the current prevalence of GDM against previously reported rates, as well as evaluating the major risk factors predisposing to the disease in the study population. Methodology Study design and setting This was a multiple hospital-based cross-sectional and observational study which was conducted at the antenatal clinics of Benue State University Teaching Hospital (BSUTH), Family Support Programme Clinic, Federal Medical Centre (FMC), First Fertility Hospital and Pishon Women Hospital all in Makurdi, Nigeria between June 2018 and February 2019 (an 8-month period). Inclusion Criteria were; pregnant women between 9 – 16 weeks gestational age as determined by early pregnancy abdominal ultra-sound scan, no known history of diabetes mellitus prior to index pregnancy, as well as Informed and consenting participants. Exclusion Criteria were; known diabetics prior to index pregnancy, acutely or chronically ill patients (associated with stress-induced derangement in glucose control which will interfere with OGTT), medications known to affect glucose metabolism like glucocorticoids, those booked outside 9 – 16 weeks gestational age and non-consenting subjects. A total 356 women who met the inclusion criteria were recruited into the study at their 9 to 16 weeks of gestation. However, only 281 who completed the study (OGTT at 24 to 28 weeks gestation) were included in the statistical analysis. Participants who met the inclusion criteria were selected using a computer-generated random number table from pregnant women attending antenatal clinic at the study sites after informed written consent had been obtained. Pregnant women known to be acutely or chronically ill, diabetic, on steroids or booked outside 9 – 16 weeks gestational age were excluded from the study. Also, participants with missing data were excluded from the study during statistical analysis. Data collection Data on demographic characteristics and relevant maternal clinical risk factors for GDM of consenting participants was obtained from antenatal booking records and by use of a validated and structured study proforma. Diagnosis of GDM At 24 – 28 weeks gestational age participants were subjected to OGTT with an oral load of 75 gram of anhydrous glucose after ensuring they maintain normal diet and activity for at least 3 days prior to testing. Samples for blood glucose assay were collected into vacutainer tubes with fluoride oxalate, separated within 20 minutes of collection and each batch was analysed immediately after collection. The diagnosis of GDM was according to the updated international diagnostic criteria based on the International Association of Diabetes in Pregnancy Study Group (IADPSG) diagnostic guideline for universal testing of women [24] between 24 – 28 weeks gestation. GDM was diagnosed if fasting blood glucose level ≥ 5.1mmol/L, and/or 1-hour post-75g blood glucose level ≥ 10.0mmol/L, and/or 2-hour post-75g blood glucose level ≥ 8.5mmol/L. Statistical analyses Data analysis was done using the Statistical Package for Social Sciences (SPSS) version 21. Categorical variables like history of first-degree relatives with DM, previous foetal macrosomia, etc., were represented in binary form and reported as percentages while continuous variables like age and BMI were expressed as mean ± SD. Comparison of means of continuous independent variables in both GDM and non-GDM participants was done using the student's T-test while the Chi square test was used for categorical independent variables. p-values < 0.05 were considered statistically significant in both univariate and multivariate analyses. Factors found to be statistically significant in univariate analysis were included in a multivariate model to identify independent risk factors for GDM after adjusting for potential confounders. Ethical consideration Ethical approval was obtained from the Health Research and Ethics Committees of BSUTH Makurdi before commencement of the study. The standard requirements of the Ethics Committee of the BSUTH where this work was done was satisfactorily met. BSUTH is the apex health facility in Makurdi, its ethical clearance was accepted by the management of the other study sites. The aim and importance of the study, procedures involved, as well as the risks and benefits associated with participation in the study was explained to each participant prior to recruitment. They were allowed to raise concerns where required and clarifications were proffered. Participation in the study was entirely voluntary and they were made to understand that they may opt out of the study at any point without affecting the level of care they would receive from the hospital. Informed consent so obtained was individualized and documented as signified by the participant's signature and that of a witness. Participants were allotted number codes to ensure confidentiality after providing an informed and written consent for inclusion in the study. Data from the study proforma and results obtained from analysis of serum sample collected from the participants were kept confidential by filing in locked spaces. Result During the 8 months period of the study, a total of 356 women who met the inclusion criteria were recruited, but only 281 (79.8%) who were subsequently tested for GDM at 24 to 28 weeks of gestation were included in the study. Forty-seven (16.7%) of the women had GDM based on result of one-step 75g OGTT diagnostic method while 234 (83.3%) were without GDM. Table 1 shows the socio-demographic and clinical characteristics of the participants. There were no statistically significant differences between GDM and non-GDM participants with regards to age groups, ethnicity, educational status, religion, parity and blood pressures. Table 1Some socio-demographic and clinical characteristics of the study participantsCharacteristicsTotal(n=281)Mean±SD orn (%)GDM (n=47)Mean±SD orn (%)Non-GDM(n=234)Mean±SD orn (%)p-valueAge groups (years) < 2552 (18.5)4 (7.7)48 (92.3)0.088 25 – 35202 (71.9)36 (17.8)166 (82.2) > 3527 (9.6)7 (25.9)20 (74.1)Ethnic groups Tiv156 (55.5)33 (21.2)123 (78.8)0.066 Idoma62 (22.0)4 (6.5)58 (93.5) Igbo33 (11.7)6 (18.2)27 (81.8) Others30 (10.7)4 (13.3)26 (86.7)Educational status Uneducated66 (23.5)14 (21.2)52 (78.8)0.250 Primary58 (20.6)13 (22.4)45 (77.6) Secondary65 (23.1)8 (12.3)57 (87.7) Tertiary92 (32.7)12 (13.0)80 (87.0)Religion Christian237 (84.3)40 (16.9)197 (83.1)0.538 Muslim44 (15.7)7 (15.9)37 (84.1)Parity Primigravida94 (33.5)11 (11.7)83 (88.3)0.074 Multigravida187 (66.5)36 (19.3)151 (80.7)Blood Pressure Systolic (mmHg)108.1 ± 10.9107.9 ± 10.6108.2 ± 10.90.690 Diastolic (mmHg)72.6 ± 10.872.5 ± 10.873.0 ± 10.40.961 Some socio-demographic and clinical characteristics of the study participants Table 2 shows the relationship between maternal clinical risk factors for GDM and development of the disease. The mean age of the participants was 29.2 ± 4.8 years. Women who developed GDM had a significantly higher mean age of 31.2 ± 4.6 years compared to those without GDM (28.7 ± 4.8 years) (p = 0.001). The mean early pregnancy BMI of the study participants was 28.4 ± 5.3 kg/m2. Those who developed GDM had a statistically significant higher BMI (32.1 ± 4.9 kg/m2) compared to those who did not (27.6 ± 5.1 kg/m2) (p < 0.001). Statistically significant differences between GDM versus non-GDM women were also noted in some maternal clinical risk factors for GDM like having a previous history of GDM (83.3% vs 16.7%; p=0.001), first degree relatives with diabetes mellitus (68.9% vs 31.1%; p=0.001) and history of foetal macrosomia (71.0% vs 29.0%; p=0.004) on univariate analysis, while participants with history of perinatal loss, multiple pregnancies and/or pre-eclampsia in their previous pregnancies showed no statistically significant differences between GDM and non-GDM participants. However, after a multivariate logistic regression analysis with sequential backward elimination and adjusting for confounding variables, only early pregnancy BMI (adjusted OR = 1.154, 95% CI = 1.080 – 1.233, p<0.001) and family history of diabetes mellitus (adjusted OR = 0.482, 95% CI = 0.233 – 0.997, p=0.049) were independent risk factors for GDM in the cohort. Table 2Risk factors for gestational diabetes mellitus in the cohortCharacteristicsTotal(n=281)Mean±SD orn (%)GDMMean±SD orn (%)Non-GDMMean±SD orn (%)p-valueAge (years)29.2 ± 4.831.2 ± 4.628.7 ± 4.80.001*Early pregnancy BMI (kg/m2)28.4 ± 5.332.1 ± 4.927.6 ± 5.1<0.001*Previous history of GDM6 (2.1)5 (83.3)1 (16.7)0.001*History of first-degree relation with diabetes mellitus61 (21.7)42 (68.9)19 (31.1)0.001*History of perinatal loss37 (13.2)28 (75.7)9 (24.3)0.138History of multiple pregnancies19 (6.8)13 (68.4)6 (31.6)0.076Foetal macrosomia in previous pregnancies62 (22.1)44 (71.0)18 (29.0)0.004*History of Pre-eclampsia15 (5.3)11 (73.3)4 (26.7)0.229 Risk factors for gestational diabetes mellitus in the cohort Discussion The pooled prevalence of GDM based on updated international diagnostic criteria in Africa is 13.6% (95% CI: 11.0 – 16.2) while in the sub-Saharan African region, an estimated prevalence of 14.3% has been reported.20 In Nigeria, a systematic review reported a pooled prevalence of 11.0% (95% CI: 8.0 – 13.0),25 and a prevalence of 8.3% has been earlier reported in a similar population of pregnant women in the North-Central region of Nigeria.26 The high prevalence of GDM in this study (16.7%) based on updated criteria may be in keeping with the high burden of the disease in the region and its progressive increase over time.11, 19 This is consistent with a recent systematic review and meta-analysis that reports a GDM prevalence of 16.0% (95% CI: 8.0 – 25.0) in the sub-Saharan African region.25 This high prevalence from both studies may be attributable to increasing maternal age and BMI, changes in diagnostic criteria and/or definition of GDM, as well as other lifestyle changes linked to urbanization which has also been associated with increasing prevalence of T2DM in the sub-Saharan African region.27 An important determinant of GDM prevalence is the chosen diagnostic approach. Reports from previous studies showed that the IADPSG criteria has better sensitivity than other diagnostic criteria and is capable of detecting more women with GDM.28, 29 The prevalence of GDM in the index study was far higher that of a previous hospital-based study carried out in the same geographical region where a point prevalence of 8.3% was obtained.[26] Despite the mean age of the participants in that study being similar to that in the index study, remarkable difference in prevalence is mostly accounted for by the chosen diagnostic methods.30, 31 In that study, a 75g OGTT was done after an initial screening via 1-h 50g glucose challenge test (GCT). This two-step approach has lower sensitivity compared to the one-step 75g OGTT approach used in this study 32, 33 However, use of same diagnostic approach yielded a lower prevalence rate (11.6%) in a previous study of a cohort of pregnant women receiving ante-natal care in Lagos, South-West Nigeria and higher in a more recent study in South-East Nigeria (38.0%) when compared to the index study.34, 35 This may be due to progressive increase in GDM prevalence as a result of changes in maternal clinical and demographic characteristics over time, higher detection rates as a result of improved diagnosis of GDM, and/or sociocultural, environmental, and economic factors, resulting in differences in accessing ANC services, as well as other population lifestyle differences. Another factor that may impact GDM prevalence is changing definitions of GDM. The IADPSG based diagnostic criteria utilized in this study usually reports a higher prevalence because it includes hyperglycaemia levels categorized as Diabetes in Pregnancy (DIP) by the 2013 WHO criteria in the definition of GDM, provided it was first recognized in pregnancy. For instance, a previous study aimed at determining the prevalence of GDM in South-East Nigeria reported a higher prevalence (38.0%) using the IADPSG criteria compared to the 2013 WHO criteria (35.9%). The difference is primarily because a further 2.1% was classified as having DIP by the 2013 WHO criteria,35 while all subjects without prior history of diabetes mellitus identified to have any degree of hyperglycemia in pregnancy were classified as GDM by the IADPSG criteria. Other factors like ethnicity, increasing maternal age and BMI may have contributed to the increase in GDM prevalence. Ethnicity (black race) have been found to be associated with higher levels of insulin resistance 36–38 and contributes to the high incidence of GDM amongst Africans. However, key factors that may affect GDM prevalence in the region are the increasing incidence of obesity39 and the progressive increase in maternal age.13, 40 For instance, the mean age of the participants in this study is 29.2 ± 4.8 years which is higher than the recommended cut-off of 25 years indicative of a high risk of GDM from previous studies.41, 42 Similarly, the mean early pregnancy BMI of the participants (28.4 ± 5.3 kg/m2) fell within the overweight category (25.0 – 29.9 kg/m2) and BMI greater than 25 kg/m2 has been strongly associated with high risk of GDM.43 This has been reported in a recent Chinese study where early pregnancy BMI in the overweight/obese category was associated with increased risk of maternal GDM.44 This higher BMI and obesity has been known to strongly correlate with increased insulin resistance and glucose intolerance45 which in pregnancy causes GDM. Furthermore, this study also assessed the major risk factors predisposing to GDM in the study population. Risk factors associated with GDM development in this study are as reported in previous studies carried out in sub-Saharan Africa. 11, 19, 20, 26, 46 However, only increased early pregnancy BMI and having a family history of diabetes mellitus were significant independent risk factors for GDM in the cohort with an adjusted OR of 1.154 (95% CI = 1.080 – 1.233, p < 0.001) and 0.482 (95% CI = 0.233 – 0.997, p<0'05 respectively. When compared with a previous study from a similar population within the region, previous foetal macrosomia was the only independent predictor of GDM in that study (adjusted OR 11.1; 95 % CI 2.93 – 42.12, p<0.001. Difference in these findings as well as other risk factors in the multivariate model being insignificant is possibly due to the shorter duration of the study, smaller sample sizes and/or presence of some unknown confounding factors in both cohorts. A larger study would be required to identify other risk factors for GDM in the region. This study carried out a one-time point assessment for GDM (24 – 28 weeks of gestation) and participants were not followed up to assess for birth outcome and subsequent post-delivery testing for GDM. As such, the study cannot reliably claim a causal relationship between identified risk factors and GDM development. We recommend further studies with a larger sample size and study duration to better assess risk factors for GDM development throughout the period of pregnancy and the post-delivery period in the region. Conclusion There has been a remarkable rise in the prevalence of GDM in the North-Central region of Nigeria over time which may be attributable to increasing maternal age and BMI, changes in diagnostic criteria and/or definition of GDM, and lifestyle changes amongst other possible reasons. Acknowledgement We acknowledge the managements of Benue State University Teaching Hospital (BSUTH), Pishon Women Hospital, Federal Medical Center (FMC), Family Support Program Clinic, and First Fertility Hospital for granting us access to patients attending ANC at their centers. We also acknowledge Dr. F. Dogoh of Department of Chemical Pathology, Benue State University Teaching Hospital, Makurdi for his assistance in patient preparation and sample collection during recruitment and OGTT References